BAM
AVNS

Belpointe Asset Management’s Avanos Medical AVNS Stock Holding History

Belpointe Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-826
Closed -$24.6K – 793
2023
Q1 		$24.6K Buy
826
+15
+2% +$435 ﹤0.01% 2184
2022
Q4 		$21.9K Buy
+811
New +$19.8K ﹤0.01% 2115

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Belpointe Asset Management's AVNS Position: Q2 2023 in Review

Belpointe Asset Management sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 826 shares — an estimated $24.6K sold.

Belpointe Asset Management first reported a position in AVNS in Q4 2022 and held it in 2 quarters. The position peaked at $24.6K in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Belpointe Asset Management reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 826 Avanos Medical shares in Q2 2023, an estimated $24.6K.
  • Belpointe Asset Management first reported a position in Avanos Medical in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Avanos Medical position peaked at $24.6K in Q1 2023.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.